Evidence map›Paper›PMID 36424930›Full record

ReviewFrontiers in nutrition2022

Valorizing the usage of olive leaves, bioactive compounds, biological activities, and food applications: A comprehensive review.

Samy Selim, Mha Albqmi, Mohammad M Al-Sanea, Taghreed S Alnusaire, Mohammed S Almuhayawi, Hamada AbdElgawad, Soad K Al Jaouni, Amr Elkelish, Shaimaa Hussein, Mona Warrad and 1 more

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in nutrition, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
10.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 106 citations in OpenAlex.

  1. Article
  2. Development of FunctionalFoods (Basel, Switzerland) · 2026
    Article
  3. A comprehensive review ofRSC advances · 2026
    Review
  4. Article
  5. Article
  6. ExploitingAntioxidants (Basel, Switzerland) · 2026
    Article
  7. An Integrated Approach to Evaluate the Influence of DietaryAnimals : an open access journal from MDPI · 2026
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Effects of Olive Leaf (Animals : an open access journal from MDPI · 2025
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Samy SelimDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Sakaka, Saudi Arabia.
Mha AlbqmiOlive Research Center, Jouf University, Sakaka, Saudi Arabia.
Mohammad M Al-SaneaDepartment of Pharmaceutical Chemistry, College of Pharmacy, Jouf University, Sakaka, Saudi Arabia.
Taghreed S AlnusaireDepartment of Biology, College of Science, Jouf University, Sakaka, Saudi Arabia.
Mohammed S AlmuhayawiDepartment of Medical Microbiology and Parasitology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
Hamada AbdElgawadDepartment of Botany and Microbiology, Faculty of Science, Beni-Suef University, Beni-Suef, Egypt.
Soad K Al JaouniDepartment of Hematology and Oncology, Yousef Abdulatif Jameel Scientific Chair of Prophetic Medicine Application, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
Amr ElkelishDepartment of Botany and Microbiology, Faculty of Science, Suez Canal University, Ismailia, Egypt.
Shaimaa HusseinDepartment of Pharmacology, College of Pharmacy, Jouf University, Sakaka, Saudi Arabia.
Mona WarradDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences at Al-Quriat, Jouf University, Al Qurayyat, Saudi Arabia.
Mohamed T El-SaadonyDepartment of Agricultural Microbiology, Faculty of Agriculture, Zagazig University, Zagazig, Egypt.
Al Jouf University · SAKing Abdulaziz University · SABeni-Suef University · EGSuez Canal University · EGZagazig University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Olive oil production is a significant source of economic profit for Mediterranean nations, accounting for around 98 percent of global output. Olive oil usage has increased dramatically in recent years, owing to its organoleptic characteristics and rising knowledge of its health advantages. The culture of olive trees and the manufacture of industrial and table olive oil produces enormous volumes of solid waste and dark liquid effluents, involving olive leaves, pomace, and olive oil mill wastewaters. These by-products cause an economic issue for manufacturers and pose major environmental concerns. As a result, partial reuse, like other agronomical production wastes, is a goal to be achieved. Because these by-products are high in bioactive chemicals, which, if isolated, might denote components with significant added value for the food, cosmetic, and nutraceutical sectors, indeed, they include significant amounts of beneficial organic acids, carbohydrates, proteins, fibers, and phenolic materials, which are distributed differently between the various wastes depending on the olive oil production method and table olive agronomical techniques. However, the extraction and recovery of bioactive materials from chosen by-products is a significant problem of their reasonable value, and rigorous detection and quantification are required. The primary aims of this review in this context are to outline the vital bioactive chemicals in olive by-products, evaluate the main developments in extraction, purification, and identification, and study their uses in food packaging systems and safety problems.

Indexed as

anticancerantimicrobialantioxidantfood applicationolive oil products

Identifiers

PMID36424930
PMCPMC9678927
OpenAlexW4308593374

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.